Log In
Print this Print this

Captisol enabled Vfend, voriconazole

  Manage Alerts
Collapse Summary General Information
Company Ligand Pharmaceuticals Inc.
DescriptionCaptisol enabled triazole antifungal agent
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationCandida
Indication DetailsTreat candida infections; Treat candidemia in non-neutropenic patients
Regulatory Designation
PartnerPfizer Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today